Exercise Combined with Electrotherapy Enhances Motor Function in an Adolescent with Spinal Muscular Atrophy Type III.
Journal
Case reports in neurological medicine
ISSN: 2090-6668
Titre abrégé: Case Rep Neurol Med
Pays: United States
ID NLM: 101576451
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
11
2018
revised:
08
03
2019
accepted:
09
07
2019
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
21
8
2019
Statut:
epublish
Résumé
Electrotherapy is widely used in physical therapy to increase muscle mass, improve motor function, and assist physical activity in several neurologic conditions. However, concerning Spinal Muscular Atrophy (SMA), limited evidence exists on the role of electrotherapy as an adjunct for improving muscle strength and function. An adolescent (13 y.o.) with SMA type III underwent an 18-week strengthening program divided into two stages. During Phase I (weeks: 1-8), a home-based program for quadriceps strengthening through neuromuscular electrical stimulation (NMES) was provided. In Phase II (weeks: 9-18), at-home NMES was combined with functional electrical stimulation (FES) assisting volitional cycling for a broader, systemic conditioning. The treatment improved patient's structural and functional motor outcomes (quadriceps circumference and strength, Tinetti scale, and Hammersmith scale) as well as independence in stair climbing. The purpose of this report is to raise awareness of the potential role of electrotherapy to help improving motor performance in SMA patients and, secondly, to foster further research aimed at assessing the actual contribution this intervention may have as an add-on therapy to existing care.
Sections du résumé
BACKGROUND
BACKGROUND
Electrotherapy is widely used in physical therapy to increase muscle mass, improve motor function, and assist physical activity in several neurologic conditions. However, concerning Spinal Muscular Atrophy (SMA), limited evidence exists on the role of electrotherapy as an adjunct for improving muscle strength and function.
CASE REPORT
METHODS
An adolescent (13 y.o.) with SMA type III underwent an 18-week strengthening program divided into two stages. During Phase I (weeks: 1-8), a home-based program for quadriceps strengthening through neuromuscular electrical stimulation (NMES) was provided. In Phase II (weeks: 9-18), at-home NMES was combined with functional electrical stimulation (FES) assisting volitional cycling for a broader, systemic conditioning. The treatment improved patient's structural and functional motor outcomes (quadriceps circumference and strength, Tinetti scale, and Hammersmith scale) as well as independence in stair climbing.
CLINICAL REHABILITATION IMPACT
CONCLUSIONS
The purpose of this report is to raise awareness of the potential role of electrotherapy to help improving motor performance in SMA patients and, secondly, to foster further research aimed at assessing the actual contribution this intervention may have as an add-on therapy to existing care.
Identifiants
pubmed: 31428487
doi: 10.1155/2019/4839793
pmc: PMC6679856
doi:
Types de publication
Case Reports
Langues
eng
Pagination
4839793Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest regarding the publication of this paper.
Références
Dev Med Child Neurol. 2002 Nov;44(11):741-4
pubmed: 12418614
Pediatrics. 2004 Nov;114(5):e548-53
pubmed: 15492357
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:84-5
pubmed: 15512881
Physiother Res Int. 2007 Sep;12(3):175-94
pubmed: 17624871
Neuromuscul Disord. 2007 Oct;17(9-10):693-7
pubmed: 17658255
Exerc Sport Sci Rev. 2007 Oct;35(4):180-5
pubmed: 17921786
J Electromyogr Kinesiol. 2009 Aug;19(4):614-22
pubmed: 18440241
Artif Organs. 2008 Aug;32(8):625-9
pubmed: 18782133
J Sci Med Sport. 2010 Sep;13(5):496-502
pubmed: 20005170
Disabil Rehabil. 2010;32(4):336-43
pubmed: 20055572
Eur J Appl Physiol. 2010 Sep;110(2):223-34
pubmed: 20473619
Muscle Nerve. 2011 Apr;43(4):485-8
pubmed: 21404286
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Eur J Appl Physiol. 2011 Oct;111(10):2451-9
pubmed: 21717122
Nat Rev Endocrinol. 2012 Apr 03;8(8):457-65
pubmed: 22473333
Rev Neurol. 2013 Sep 1;57(5):207-11
pubmed: 23975526
Community Ment Health J. 1968 Dec;4(6):443-53
pubmed: 24185570
J Neuroeng Rehabil. 2014 Feb 25;11:17
pubmed: 24568180
Am J Med. 1986 Mar;80(3):429-34
pubmed: 3953620